ATRS insider filings

ANTARES PHARMA, INC. — 48 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-05-26. Screen ATRS transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for ATRS between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — ANTARES PHARMA, INC.

FiledFormInsiderReported transactionsSource
2022-05-264ROCHE ROBERT P JR — DirectorDisposition to issuer (D): 118,392 @ $5.60 · Disposition to issuer (D): 49,425 @ $5.60 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 61,930 (derivative) · Disposition to issuer (D): 99,395 (derivative) · Disposition to issuer (D): 150,000 (derivative) · +5 moreEDGAR
2022-05-264GUETH ANTON — DirectorDisposition to issuer (D): 386,132 @ $5.60 · Disposition to issuer (D): 1,800 @ $5.60 · Disposition to issuer (D): 79,645 @ $5.60 · Disposition to issuer (D): 61,930 (derivative) · Disposition to issuer (D): 99,395 (derivative) · Disposition to issuer (D): 150,000 (derivative) · +5 moreEDGAR
2022-05-264Richardson Peter C — See RemarksDisposition to issuer (D): 36,199 @ $5.60 · Disposition to issuer (D): 14,414 @ $5.60 · Disposition to issuer (D): 59,179 (derivative) · Disposition to issuer (D): 69,037 (derivative)EDGAR
2022-05-264Smith Karen L. — DirectorDisposition to issuer (D): 54,193 @ $5.60 · Disposition to issuer (D): 25,452 @ $5.60 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 46,729 (derivative) · Disposition to issuer (D): 58,246 (derivative) · Disposition to issuer (D): 48,542 (derivative)EDGAR
2022-05-264JACOB LEONARD S — DirectorDisposition to issuer (D): 138,901 @ $5.60 · Disposition to issuer (D): 31,674 @ $5.60 · Disposition to issuer (D): 123,860 (derivative) · Disposition to issuer (D): 198,789 (derivative) · Disposition to issuer (D): 300,000 (derivative) · Disposition to issuer (D): 160,636 (derivative) · +4 moreEDGAR
2022-05-264GRAHAM PETER J — See RemarksDisposition to issuer (D): 414,470 @ $5.60 · Disposition to issuer (D): 202,139 @ $5.60 · Disposition to issuer (D): 124,234 @ $5.60 · Disposition to issuer (D): 125,000 (derivative) · Disposition to issuer (D): 212,900 (derivative) · Disposition to issuer (D): 217,725 (derivative) · +4 moreEDGAR
2022-05-264GARRITY THOMAS J — DirectorDisposition to issuer (D): 224,406 @ $5.60 · Disposition to issuer (D): 25,452 @ $5.60 · Disposition to issuer (D): 61,930 (derivative) · Disposition to issuer (D): 99,395 (derivative) · Disposition to issuer (D): 80,318 (derivative) · Disposition to issuer (D): 76,548 (derivative) · +3 moreEDGAR
2022-05-264Powell Fred M — Executive Vice President & CFODisposition to issuer (D): 587,014 @ $5.60 · Disposition to issuer (D): 204,022 @ $5.60 · Disposition to issuer (D): 124,234 @ $5.60 · Disposition to issuer (D): 150,000 (derivative) · Disposition to issuer (D): 217,725 (derivative) · Disposition to issuer (D): 177,453 (derivative) · +3 moreEDGAR
2022-05-264APPLE ROBERT F — President and CEO, DirectorDisposition to issuer (D): 1,876,693 @ $5.60 · Disposition to issuer (D): 611,667 @ $5.60 · Disposition to issuer (D): 374,099 @ $5.60 · Disposition to issuer (D): 21,658 (derivative) · Disposition to issuer (D): 56,300 (derivative) · Disposition to issuer (D): 288,786 (derivative) · +6 moreEDGAR
2022-05-264Volkart Carmen B — DirectorDisposition to issuer (D): 55,916 (derivative)EDGAR
2022-05-264Greenleaf Peter — DirectorDisposition to issuer (D): 30,220 @ $5.60 · Disposition to issuer (D): 49,425 @ $5.60 · Disposition to issuer (D): 20,000 (derivative) · Disposition to issuer (D): 46,729 (derivative) · Disposition to issuer (D): 58,246 (derivative) · Disposition to issuer (D): 48,542 (derivative)EDGAR
2022-03-044APPLE ROBERT F — President & CEO, DirectorGrant/award (A): 86,814 @ $0 · Tax withholding (F): 37,695 @ $3.80EDGAR
2022-03-044Powell Fred M — Executive Vice President & CFOGrant/award (A): 27,780 @ $0 · Tax withholding (F): 11,506 @ $3.80EDGAR
2022-03-044GRAHAM PETER J — EVP General Counsel, SecretaryGrant/award (A): 26,044 @ $0 · Tax withholding (F): 13,635 @ $3.80EDGAR
2022-02-184GRAHAM PETER J — EVP General Counsel, SecretaryGrant/award (A): 23,068 @ $0 · Tax withholding (F): 13,299 @ $3.66EDGAR
2022-02-184Powell Fred M — Executive Vice President & CFOGrant/award (A): 24,606 @ $0 · Tax withholding (F): 11,496 @ $3.66EDGAR
2022-02-184APPLE ROBERT F — President & CEO, DirectorGrant/award (A): 76,893 @ $0 · Tax withholding (F): 34,282 @ $3.66EDGAR
2021-10-294Volkart Carmen B — DirectorGrant/award (A): 55,916 (derivative) @ $0EDGAR
2021-08-314JACOB LEONARD S — DirectorGrant/award (A): 24,679 @ $2.24 · Tax withholding (F): 13,820 @ $4 · Option exercise (M): 24,679 (derivative) @ $0EDGAR
2021-07-094GUETH ANTON — DirectorSale (S): 100,000 @ $4.29EDGAR
2021-06-144Smith Karen L. — DirectorGrant/award (A): 25,452 @ $4.42 · Grant/award (A): 48,542 (derivative) @ $0EDGAR
2021-06-144ROCHE ROBERT P JR — DirectorGrant/award (A): 25,452 @ $4.42 · Grant/award (A): 48,542 (derivative) @ $0EDGAR
2021-06-144Richardson Peter C — EVP, R&D Chief Medical OfficerGrant/award (A): 36,199 @ $4.42 · Grant/award (A): 69,037 (derivative) @ $0EDGAR
2021-06-144Powell Fred M — Executive Vice President & CFOGrant/award (A): 85,973 @ $4.42 · Tax withholding (F): 17,327 @ $4.45 · Tax withholding (F): 11,880 @ $4.45 · Grant/award (A): 163,963 (derivative) @ $0EDGAR
2021-06-144JACOB LEONARD S — DirectorGrant/award (A): 31,674 @ $4.42 · Grant/award (A): 60,407 (derivative) @ $0EDGAR
2021-06-144GUETH ANTON — DirectorGrant/award (A): 25,452 @ $4.42 · Grant/award (A): 48,542 (derivative) @ $0EDGAR
2021-06-144Greenleaf Peter — DirectorGrant/award (A): 25,452 @ $4.42 · Grant/award (A): 48,542 (derivative) @ $0EDGAR
2021-06-144GRAHAM PETER J — EVP General Counsel, SecretaryGrant/award (A): 85,973 @ $4.42 · Tax withholding (F): 23,010 @ $4.45 · Tax withholding (F): 14,790 @ $4.45 · Grant/award (A): 163,963 (derivative) @ $0EDGAR
2021-06-144GARRITY THOMAS J — DirectorGrant/award (A): 25,452 @ $4.42 · Grant/award (A): 48,542 (derivative) @ $0EDGAR
2021-06-144APPLE ROBERT F — President & CEO, DirectorGrant/award (A): 248,869 @ $4.42 · Tax withholding (F): 58,317 @ $4.45 · Tax withholding (F): 40,892 @ $4.45 · Grant/award (A): 474,629 (derivative) @ $0EDGAR
2021-06-104APPLE ROBERT F — President & CEO, DirectorTax withholding (F): 44,223 @ $4.39EDGAR
2021-06-104Powell Fred M — Executive Vice President & CFOTax withholding (F): 12,045 @ $4.39EDGAR
2021-06-104GRAHAM PETER J — EVP General Counsel, SecretaryTax withholding (F): 15,996 @ $4.39EDGAR
2021-05-064GUETH ANTON — DirectorOption exercise (M): 40,000 @ $1.66 · Option exercise (M): 40,000 (derivative) @ $0EDGAR
2021-05-034GUETH ANTON — DirectorOption exercise (M): 72,669 @ $1.66 · Option exercise (M): 72,669 (derivative) @ $0EDGAR
2021-04-284Richardson Peter C — EVP, R&D Chief Medical OfficerGrant/award (A): 59,179 (derivative) @ $0EDGAR
2021-03-124GARRITY THOMAS J — DirectorOption exercise (M): 50,000 @ $1.12 · Sale (S): 50,000 @ $4.28 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2021-03-034Powell Fred M — Executive Vice President & CFOGrant/award (A): 45,829 @ $0 · Tax withholding (F): 19,899 @ $4.50EDGAR
2021-03-034GRAHAM PETER J — EVP General Counsel, SecretaryGrant/award (A): 45,829 @ $0 · Tax withholding (F): 23,992 @ $4.50EDGAR
2021-03-034APPLE ROBERT F — President & CEO, DirectorGrant/award (A): 152,763 @ $0 · Tax withholding (F): 66,330 @ $4.50EDGAR
2021-02-194Powell Fred M — Executive Vice President & CFOGrant/award (A): 80,365 @ $0 · Tax withholding (F): 35,829 @ $4.73EDGAR
2021-02-194APPLE ROBERT F — President & CEO, DirectorGrant/award (A): 267,878 @ $0 · Tax withholding (F): 116,313 @ $4.73 · Option exercise (M): 5,519 @ $2.62 · Sale (S): 5,519 @ $4.75 · Option exercise (M): 250,000 @ $0.88 · Sale (S): 232,156 @ $5 · +4 moreEDGAR
2021-02-194JACOB LEONARD S — DirectorOption exercise (M): 15,321 @ $2.24 · Sale (S): 15,321 @ $5.05 · Option exercise (M): 15,321 (derivative) @ $0EDGAR
2021-02-194GRAHAM PETER J — EVP General Counsel, SecretaryGrant/award (A): 80,365 @ $0 · Tax withholding (F): 42,073 @ $4.73 · Option exercise (M): 45,000 @ $1.12 · Sale (S): 40,000 @ $4.91 · Sale (S): 5,000 @ $5.05 · Option exercise (M): 45,000 (derivative) @ $0EDGAR
2021-02-124GARRITY THOMAS J — DirectorOption exercise (M): 50,000 @ $1.12 · Sale (S): 50,000 @ $4.62 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2021-02-104APPLE ROBERT F — President & CEO, DirectorOption exercise (M): 33,574 @ $2.62 · Sale (S): 33,574 @ $4.75 · Option exercise (M): 49,129 @ $2.62 · Sale (S): 49,129 @ $4.75 · Option exercise (M): 7,278 @ $2.62 · Sale (S): 7,278 @ $4.75 · +3 moreEDGAR
2021-01-134GARRITY THOMAS J — DirectorOption exercise (M): 20,000 @ $2.24 · Sale (S): 20,000 @ $4.07 · Option exercise (M): 50,000 @ $1.12 · Sale (S): 50,000 @ $4.05 · Option exercise (M): 20,000 (derivative) @ $0 · Option exercise (M): 50,000 (derivative) @ $0EDGAR
2020-11-164Powell Fred M — Executive Vice President & CFOPurchase (P): 16,400 @ $2.85EDGAR

Recent 8-K events — ANTARES PHARMA, INC.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2022-05-248-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.01 — Completion of Acquisition or Disposition of Assets
2.04 — Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-04-138-K1.01 — Entry into a Material Definitive Agreement
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-078-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-03-038-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-128-K/A7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-01-118-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-12-168-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-048-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2021-11-028-K1.01 — Entry into a Material Definitive Agreement
1.02 — Termination of a Material Definitive Agreement
2.03 — Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
9.01 — Financial Statements and Exhibits
EDGAR
2021-10-288-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=ATRS returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs